Results 201 to 210 of about 19,745 (243)

Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. [PDF]

Cancers (Basel)
Bangolo A, Amoozgar B, Mansour C, Zhang L, Gill S, Ip A, Cho C.   +6 more
europepmc   +1 more source

CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting. [PDF]

J Hematol Oncol
Tomarchio V, Rigacci L, Annibali O.
europepmc   +1 more source

Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma. [PDF]

Cancer Med
Yan S, Ming X, Zheng R, Zhu X, Xiao Y.
europepmc   +1 more source

A B7-H3-Targeted CD28 Bispecific Antibody Enhances the Activity of Anti-PD-1 and CD3 T-cell Engager Immunotherapies. [PDF]

Mol Cancer Ther
Moore GL, Zeng VG, Diaz JE, Bonzon C, Avery KN, Rashid R, Qi J, Nam DH, Jacinto J, Dragovich MA, Kim YK, Balcazar KP, Bakhit CG, Eivazi A, Nguyen H, Muchhal US, Szymkowski DE, Desjarlais JR, Hedvat M.   +18 more
europepmc   +1 more source

Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy. [PDF]

Antibodies (Basel)
Shin S, Baek DS, Mellors JW, Dimitrov DS, Li W.   +4 more
europepmc   +1 more source

Reprogramming the Tumor Immune Microenvironment with ICAM-1-Targeted Antibody‒Drug Conjugates and B7-H3-CD3 Bispecific Antibodies. [PDF]

Adv Sci (Weinh)
Zhou S, Hong M, Zhao D, Li W, Yuan X, Wang Y, Li H, Yang Y, Jin T, Pan J.   +9 more
europepmc   +1 more source

Optimizing asymmetric antibody purification: a semi-automated process and its digital integration. [PDF]

MAbs
Prince C, Georgiadou D, Machatti M, Hermann M, van Puijenbroek E.   +4 more
europepmc   +1 more source

Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma. [PDF]

J Immunother Cancer
Kolbe C, Kauer J, Brinkmann B, Dreger P, Huber W, Müller-Tidow C, Dietrich S, Roider T.   +7 more
europepmc   +1 more source

Tumor-specific cytosol-penetrating antibodies for antigen- and TME-dependent intracellular cargo delivery. [PDF]

Mol Ther Oncol
Dombrowsky CS, Geyer FK, Zakharchuk D, Kolmar H.   +3 more
europepmc   +1 more source